Psyence Biomedical Ltd.
PBM
$0.5211
-$0.0122-2.29%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.48M | 1.48M | -24.78M | -24.76M | -803.20K |
| Total Depreciation and Amortization | 900.00 | 900.00 | 100.00 | 100.00 | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.33M | -2.33M | 24.71M | 24.71M | -17.60K |
| Change in Net Operating Assets | 93.00K | 93.00K | -612.40K | -613.00K | 26.70K |
| Cash from Operations | -757.90K | -757.90K | -682.30K | -662.30K | -794.10K |
| Capital Expenditure | -3.20K | -3.20K | -2.90K | -2.90K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.20K | -3.20K | -2.90K | -2.90K | -- |
| Total Debt Issued | 500.00K | 500.00K | 895.70K | 886.70K | 357.50K |
| Total Debt Repaid | -- | -- | -75.00K | -75.00K | -- |
| Issuance of Common Stock | 860.80K | 860.80K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -71.60K | -73.40K | 72.20K |
| Cash from Financing | 1.36M | 1.36M | 749.10K | 738.30K | 429.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | -- |
| Net Change in Cash | 599.70K | 599.70K | 64.00K | 73.20K | -364.40K |